Philip Morris expands Colorado Zyn investment to $1.2 billion
Philip Morris International Inc. announced a significant increase in its investment in U.S. nicotine pouch production, committing $1.2 billion to its manufacturing facility in Aurora, Colorado, by 2028. This doubles the $600 million pledged in 2024, driven by growing demand for smoke-free nicotine products. The Aurora facility has begun operations and will expand production of Zyn nicotine pouches, including the new Zyn Ultra variant introduced in June 2026, which features a softer pouch design and higher nicotine strength. The investment comes amid rising competition from British American Tobacco's Velo Plus. Beyond the U.S. market, the facility will also produce Zyn for export to Asia, Latin America, and the Caribbean, supporting Philip Morris's international expansion strategy as it reduces reliance on traditional cigarettes.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection